Wake Research Associates

Raleigh, North Carolina 27617

1 studies enrolling now · 130 studies all time

What they study most

ADHD, Abdominal Pain, Acne Vulgaris, Actinic Keratosis, Acute Treatment of Migraine, Adenoma, Adenoma Colon, Adhesive Capsulitis, Adult Subjects With Anal Fissures., Alzheimer's Disease, Alzheimer's Disease or Vascular Dementia, Amyotrophic Lateral Sclerosis

Studies at this site

• A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease — Recruiting now
• Prevention of Colorectal Cancer Through Multiomics Blood Testing — Completed
• A Study of an Adenovirus Serotype 26 Pre-fusion Conformation-stabilized F Protein (Ad26. RSV. preF) Based Respiratory Syncytial Virus (RSV) Vaccine in the Prevention of Lower Respiratory Tract Disease in Adults Aged 60 Years and Older — Completed
• Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin) — Completed
• A Study to Evaluate Dose Levels of Ad26.COV2.S Administered as a Two-dose Schedule in Healthy Adults — Completed
• A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants — Completed
• Entyvio (Vedolizumab) Long Term Safety Study — Completed
• Study Evaluating the Digestibility of Serum-Derived Bovine Immunoglobulin Protein Isolate in Healthy Adults — Completed
• A Safety Study of 3 Different Bowel Cleansing Preparations — Completed
• Dose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of Migraine — Completed
• Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis (ADvocate1) — Completed
• Dose-finding Study With ACT-132577 (Aprocitentan) in Participants With Essential Hypertension — Completed
• A Study to Evaluate the Efficacy and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis — Completed
• A Study to Evaluate Efficacy and Safety of BAC in Patient With Alzheimer's Disease or Vascular Dementia — Completed
• Study of Contraceptive Efficacy & Safety of Phexxi™ (Previously Known as Amphora) Gel Compared to Conceptrol Vaginal Gel — Completed
• Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep — Completed
• Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH) — Stopped early
• AURORA: A Study for the Efficacy and Safety of Cenicriviroc (CVC) for the Treatment of Liver Fibrosis in Adults With Nonalcoholic Steatohepatitis (NASH) — Stopped early
• Phase 2 Study of TD-9855 to Treat Fibromyalgia — Completed
• AI-EMERGE: Development and Validation of a Multi-analyte, Blood-based Colorectal Cancer Screening Test — Completed
• Study to Assess the Long Term Safety and Tolerability of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep — Completed
• Tolerability, Pharmacokinetics, and Efficacy of APD371 in Participants With Crohn's Disease Experiencing Abdominal Pain — Completed
• A Study of LY3454738 in Healthy Participants and Participants With Atopic Dermatitis — Completed
• RN624 In Adult Patients With Chronic Low Back Pain — Completed
• Long-Term Analgesic Efficacy And Safety Of Tanezumab Alone Or In Combination With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Versus NSAIDs Alone In Patients With Osteoarthritis Of The Knee Or Hip — Stopped early
• Prevention of Recurrence of Diverticulitis — Completed
• Forced-dose Titration of SPD489 in Adults With Binge Eating Disorder — Completed
• Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) — Completed
• Open Label Extension in Adults With Binge Eating Disorder (BED) — Completed
• A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy — Completed
• Study of Dexpramipexole Chronic Sinusitis With Nasal Polyps and Eosinophilia — Completed
• Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008 — Completed
• Phase 3 Papulopustular Rosacea Study — Completed
• A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (25) — Completed
• A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients — Completed
• Dasotraline Binge Eating Disorder Extension Study — Completed
• A Study of GDC-0134 to Determine Initial Safety, Tolerability, and Pharmacokinetic Parameters in Participants With Amyotrophic Lateral Sclerosis — Completed
• Multi-Center Study of New Medications to Treat Vaginal Infections — Completed
• Randomized Single-Blinded Study to Evaluate Safety and Immunogenicity of Recombinant Plague Vaccine With and Without Adjuvant — Completed
• Multi-Center Study of New Medications to Treat Vaginal Infections — Completed
• Multi-Center Study of New Medications to Treat Vaginal Infections — Completed
• A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD) — Stopped early
• A Study to Evaluate a Drug (Dasotraline) on the Safety, Effectiveness and How Well the Body Tolerates it, in Adults With Moderate to Severe Binge Eating Disorder — Completed
• Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Women With Diabetic Gastroparesis — Completed
• Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Men With Diabetic Gastroparesis — Completed
• A Safety and Efficacy Study of DCL-101 Compared to GoLYTELY — Completed
• Safety and Effectiveness of BPL HRIG With Active Rabies Vaccine in Healthy Subjects — Completed
• A Safety and Efficacy Study of AGN-214868 in Patients With Postherpetic Neuralgia — Stopped early
• SP-304 Dose Ranging Study in Patients With Chronic Idiopathic Constipation — Completed
• Study to Assess the Efficacy and Safety of Rifaximin Administered BID in the Treatment of Patients With Diarrhea-Associated Irritable Bowel Syndrome — Completed